| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |